This article is mentioned in:

Introduction

Although hair loss does not generally represent a serious health issue, it is a matter of interest as it may reduce confidence and lead to social anxiety, particularly in patients with alopecia, who manifest psychiatric symptoms, including depression, social phobia and anxiety, compared with normal individuals (1,2). Hair loss in humans may be triggered by diverse factors, including mental stress, heredity and drug therapy (i.e., anti-thyroid agents and retinoids) (2,3). Alopecia may be largely divided into the following categories: Androgenetic alopecia (AGA), alopecia areata and telogen effluvium (TE) (4). Therefore, the treatment and management of alopecia depends on the cause and type of alopecia (2,3,5).

Certain studies have suggested that abnormal inflammatory response in the hair follicles may affect hair loss (6,7). In addition, growth factors have a pivotal role in hair regrowth and elongation (8–10). Therefore, the modulation of inflammatory response by inflammatory cytokines and the enhancement of growth factors represent crucial approaches in the management of hair loss (3,8,11).

The pine tree belongs to the family of Pinaceae and various parts of the pine tree, including cones, bark and needles, have been used as an alternative medicine for numerous diseases (12). Among the parts of the pine tree, the bark has been used as a traditional remedy and nutritional supplement (13,14). In particular, the extract from the bark of pine trees grown near the seashore displays strong biological attributes. For instance, PineXol®, a commercialized extract from Korean red pine (Pinus densiflora) bark, is used as an additive in health functional foods and cosmetics due to its anti-inflammatory, antioxidant and anti-lipogenic activities (15,16). In addition, Pycnogenol®, a standardized extract derived from the bark of French coastal pine (Pinus pinaster Aiton) has moisturizing properties and improves the elasticity of human skin by increasing hyaluronic acid and collagen type I (17). These maritime pine bark extracts contain abundant phenols, flavonoids and proanthocyanidins (12,18).

To the best of our knowledge, no previous studies have reported hair growth promotion using the extract from the bark of Pinus thunbergii grown near the seashore . Therefore, the aim of the present study was to investigate whether rich phenols and flavonoids were contained in the Pinus thunbergii bark extract (PBE) and the effects of PBE on hair growth was investigated using C57BL/6 mice, which represent good animal models for the study of the hair cycle due to truncal pigmentation only during the anagen phase (19,20). In addition, a previous study reported a subtle inflammatory response in hair follicles under normal conditions (21). Thus, it was investigated whether hair growth was promoted by moderating inflammatory responses after PBE application based on changes in pro- and anti-inflammatory cytokines. Furthermore, in the present study, PBE-induced changes in growth factors were assessed.

Materials and methods

Preparation of PBE

Pinus thunbergii growing next to the seashore of Gangneung (Republic of Korea) was gathered and its outer bark was harvested (specimen no., KNKA201106224024; Korea National Arboretum, Gyeonggi, Republic of Korea). The bark was washed with pure water and fully dried. Subsequently, using an M20 grinder (IKA), the dehydrated bark was pulverized into a fine powder. The powder (10 g/kg) was extracted with pure water (100 l) at 100°C for 24 h three times and the extract was then filtered using a filter paper (Whatman no. 1; Whatman Ltd.). The extract was then concentrated with a vacuum evaporator (N-12; Eyela Singapore Pte. Ltd.) and the evaporated extract was rapidly freeze-dried at −55°C using a lyophilizer (FD8512; ilShin BioBase Co. Ltd.) and stored at −20°C. The extraction yield was 1.4%.

Qualitative analysis of PBE

The total phenol contents were determined by Folin-Ciocalteu's colorimetric method (22) using gallic acid as a standard for the calibration curve. The sample solution (1 ml) was mixed with 10% Folin-Ciocalteu reagent (1 ml) and 0.2% Na2CO3 reagent (1 ml) and incubated for 1 h in the dark. Using a microplate reader (Molecular Devices, LLC), the reaction was monitored by measuring the absorbance at 750 nm and the results were calculated (y=14.39× + 0.0117, R2=0.9968) as gallic acid equivalents (GAE).

The total flavonoid contents were determined by the aluminum nitrate method (23) using quercetin as a standard for the calibration curve. The sample solution (0.5 ml) was mixed with 95% EtOH (1.5 ml), 10% aluminum nitrate (0.1 ml), 1 M potassium acetate (0.1 ml) and distilled water (DW; 2.8 ml) and incubated room temperature for 30 min. Using a microplate reader (Molecular Devices, LLC), the reaction was monitored by measuring the absorbance at 415 nm and the results were calculated (y=1.6385× + 0.0382, R2=1.0000) as quercetin equivalents (QE).

Male C57BL/6 mice (total n=40; age, 7 weeks; body weight, 26±2 g) were provided by the Experimental Animal Center of Kangwon National University (Chuncheon, South Korea). They were housed under conventional conditions at a temperature of 24°C and relative humidity of ~55% with a 12-h light/dark cycle and ad libitum access to food and water. The mice used in this experiment were randomly grouped (n=10 in each group) as follows: i) Control group, which was treated with DW, and the ii) 1, iii) 2 and iv) 4% PBE groups, which were respectively treated with 1, 2 and 4% PBE.

The experimental procedures using the experimental mice strictly adhered to the ‘Current international laws and policies’ of the ‘Guide for the Care and Use of Laboratory Animals’ (24) and the experimental protocol was approved by the Institutional Animal Care and Use Committee of Kangwon National University (Chuncheon, Republic of Korea; approval no., KW-200114-1; approval date, January 22, 2020). Humane endpoints were not established as the protocol of the current animal experiment did not cause any severe pain or stress.

In accordance with precedent studies by our group (3,25), topical application with PBE was performed. In brief, the mice were shaved on their dorsal skin. PBE was dissolved in DW and three days after shaving, 200 µl of DW or PBE (1, 2 or 4%) was topically applied on the dorsal skin twice a day for 17 days.

The HGPS was recorded as described previously (8). In short, it was scored by observing the skin with the naked eye based on the criteria of hair growth stages as follows: 0, pink-colored shaved skin; 1, gray-colored shaved skin; 2, black-colored shaved skin; 3, initiation of hair growth on the shaved skin; 4, completely grown hair on the shaved skin.

The histological sections of the dorsal skin were prepared according to a previously described method (25). In brief, at 17 days after the initiation of the topical application with DW and PBE (1, 2 and 4%), the mice were deeply anesthetized by an intraperitoneal injection of pentobarbital sodium 200 mg/kg (JW Pharm. Co., Ltd.) (26). Under deep anesthesia, they were perfused with saline (0.85% NaCl w/v; pH 7.4; flow rate, 3.0 ml/min) through the left ventricle. Subsequently, to fix the skin tissue, they were perfused with 4% paraformaldehyde. Thereafter, their dorsal skin tissues were removed and the tissues were further fixed by soaking them in the same fixative at room temperature for 6 h. The skin tissue was then embedded in a paraffin wax block for sectioning, and sections (8-µm thickness) were obtained using a microtome (Leica Microsystems).

To investigate changes in the epidermis and dermis, including hair follicles, following the topical application of DW and PBE, H&E staining was performed as described previously (3,27). The prepared sections were stained with Gill's hematoxylin solution (Merck KGaA) for 8 min followed by eosin Y solution (Merck KGaA) for 3 min. These sections were then dehydrated by immersing them in a dilution series of ethyl alcohol (50, 70, 80, 90, 95 and 100% for 1 min, respectively) and then cleared with xylene for 5 min. Finally, these stained sections were semipermanently preserved by mounting cover glasses with Canada balsam (Kanto Chemical Co., Inc.).

To compare histopathological changes in the dorsal skin between the groups, the digital images of the sections stained with H&E were captured from 5 sections per animal with a light microscope (BX53; Olympus Corporation) connected to a PC monitor. The H&E-stained hair follicles were counted using an array of 255×255 pixels corresponding to a tissue area of 250 µm2.

To examine alterations in inflammatory cytokines and growth factors in the dorsal skin tissues between the groups, immunohistochemical staining was performed in accordance with certain previous studies with minor modifications (3,28). In brief, the tissue sections were reacted with 0.3% hydrogen peroxide for 20 min at room temperature. Subsequently, they were immersed in 5% normal horse or goat serum (Vector Laboratories Inc.) for horse anti-mouse IgG and goat anti-rabbit IgG respectively at room temperature for 30 min. Thereafter, these sections were immunoreacted with each primary antibody (Table I) at 4°C for 24 h. Subsequently, they were reacted with the corresponding secondary antibody, as presented in Table I, at room temperature for 2 h and were then incubated in Elite avidin-biotin enzyme complex (Vector Laboratories, Inc.) at room temperature for 1 h at room temperature. Thereafter, the visualization of labeling was achieved using 3,3′-diaminobenzidine tetrahydrochloride solution (MilliporeSigma) for two min at room temperature. Finally, these sections were rinsed, dehydrated in a dilution series of ethyl alcohol (70, 80, 90, 95 and 100%), cleared in xylene and mounted with coverslips and Canada balsam.

Table I. Primary and secondary antibodies for immunohistochemical staining.

Table I.

Primary and secondary antibodies for immunohistochemical staining.

A, Primary antibodies
Antibody	Dilution	Supplier (cat. no.)
Rabbit anti-TNF-α	1:1,000	Abcam (ab6671)
Rabbit anti-IL-1β	1:200	Santa Cruz Biotechnology, Inc. (sc-12742)
Rabbit anti-IL-4	1:200	Santa Cruz Biotechnology, Inc. (sc-12723)
Mouse anti-IL-13	1:200	Santa Cruz Biotechnology, Inc. (sc-393365)
Rabbit anti-IGF-I	1:200	Santa Cruz Biotechnology, Inc. (sc-9013)
Mouse anti-VEGF	1:300	Abcam (ab69479)
B, Secondary antibodies
Antibody	Dilution	Supplier (cat. no.)
Biotinylated horse anti-mouse IgG	1:250	Vector Laboratories, Inc. (BA-2000)
Biotinylated goat anti-rabbit IgG	1:250	Vector Laboratories, Inc. (BA-1000)
IGF, insulin-like growth factor.

Immunoreactivity for each analyte protein in each group was evaluated using the relative optical density (ROD) of each immunoreactive structure according to a previously described method (3,8). In brief, five sections per mouse were used and observed using a light microscope (BX53) from Olympus Corporation, as described in the chapter on H&E staining. The image was captured in a corresponding tissue area of 140×140 µm2 and calibrated into an array of 256×256 pixels. Each immunoreactive structure was quantified as the ROD using a 0-255 gray scale system and software (ImageJ; v.1.46; National Institutes of Health). In this experiment, the ratio of the ROD was calibrated by setting the ROD of the control to 100%.

Data obtained in this research were expressed as the mean ± standard error of the mean. The present data were statistically analyzed using SPSS 18.0 software (SPSS, Inc.). Statistical significance was established using one-way ANOVA with a post hoc Bonferroni test for all pairwise comparisons in a multiple-group situation. The Kruskal-Wallis followed by Dunn's test were used in order to statistically analyze the hair growth promoting scores. P<0.05 was considered to indicate statistical significance.

Results

Total polyphenol and flavonoid contained in PBE

The total polyphenol and flavonoid content contained in PBE was determined to be 197.89±0.66 mg GAE/g and 48.82±0.14 mg QE/g, respectively, and the ratio of total flavonoid vs. total polyphenol was 0.2467±0.0015 (data not shown).

Hair growth-promoting effect of PBE

First, hair growth in each group was evaluated by qualitative observation and scoring (Fig. 1). In the control group, pink-colored dorsal skin was apparent until 10 days of topical application of DW (Fig. 1A-a and B-a). In this group, gray- and black-colored dorsal skin with short hairs was sparsely present at 17 days of DW application (Fig. 1C-a). In the 1% PBE group, the progress of hair growth at 10 days of 1% PBE application was not different from that in the control group (Fig. 1A-b, B-b and D). At day 17, in this group, gray-colored dorsal skin was apparent and a significant progression of hair growth was observed compared with that in the control group (Fig. 1C-b and D). On the other hand, in the 2 and 4% PBE groups, hair growth was significantly promoted at 10 days of application compared with that in the control group (Fig. 1B-c, B-d and D). In addition, at day 17, fully grown fur was detected in these two groups (Fig. 1C-c, C-d and D). Based on this observation, it was indicated that the most effective promotion of hair growth was accomplished by application of 2% PBE. Thus, the following histological investigations were performed with 2% PBE. Among the four groups, there was no site-specific allergic reaction and no change in body weight was observed after topical application of DW of PBE (1, 2 and 4%) (data not shown).

Figure 1. (A-C) Hair growth process in the dorsal skin of the (a) control, (b) 1%, (c) 2% and (d) 4% PBE groups at (A) day 1, (B) day 10 and (C) day 17. At 10 days, in the control and 1% PBE groups, a pink-colored skin area is observed, whereas, at this time-point, in the 2 and 4% PBE groups, a gray- and black-colored skin area is present. Complete hair growth is observed at 17 days in the 2 and 4% PBE groups. (D) Hair growth-promoting scores. The bars indicate the means ± standard error of the mean (n=10 in each group). *P<0.05 vs. control group; #P<0.05 vs. 1% PBE group. PBE, Pinus thunbergii bark extract.

Effect of PBE on hair follicles

As presented in Fig. 2, the histology of the dorsal skin containing hair follicles in the PBE group was compared with that in the control group at 17 days of PBE treatment using H&E staining (blue by hematoxylin and purple by eosin). In the control group, a typical morphology of the hair follicles was observed (Fig. 2A). In the PBE group, the stainability with H&E and cellular morphology in the hair follicles were not significantly different from those in the control group (Fig. 2B).

Figure 2. H&E staining in the dorsal skin of (A) the control and (B) 2% PBE groups at 17 days after the topical application of distilled water and 2% PBE, respectively (scale bar, 50 µm). No significant difference was detected in their hair follicles (arrows) between the two groups. (C) Mean numbers of hair follicles and (D) mean thickness of epidermis. The bars indicate the means ± standard error of the mean (n=10 in each group). Ep, epidermis; D, dermis; HF, hair follicle; PBE, Pinus thunbergii bark extract.

In the control group, the numbers of hair follicles and epithermal thickness (8.1/250 µm2 and 16.6 µm, respectively) were not significantly different from those in the PBE group (7.9/250 µm2 and 16.7 µm; Fig. 2C and D, respectively). In addition, no infiltration of inflammatory cells was observed in the dorsal skin following topical application of DW of PBE in any of the groups (Fig. 2A and B).

Effect of PBE on pro-inflammatory cytokines

The effect of PBE on inflammatory cytokines was then assessed (Fig. 3). At 17 days of treatment, TNF-α immunoreactivity in the skin of the control group was principally detected in the hair follicles (Fig. 3A). In the PBE group, significantly weakened TNF-α immunoreactivity (37.0% vs. control group) was observed as compared with that in the control group (Fig. 3B and E).

Figure 3. (A-D) Immunohistochemical analysis of TNF-α and IL-1β in the dorsal skin at 17 days after the application. TNF-α in (A) the control group and (B) 2% PBE group. IL-1β in (C) the control and (D) 2% PBE group. In the 2% PBE group, the immunoreactivities of TNF-α and IL-1β were significantly lower (arrows) than those in the control group (scale bar, 50 µm). RODs of (E) TNF-α and (F) IL-1β in the dorsal skin at 17 days after the application. The bars indicate the means ± standard error of the mean (n=10 in each group). *P<0.05 vs. control group. PBE, Pinus thunbergii bark extract; ROD, relative optical density.

In addition, strong IL-1β immunoreactivity was obtained in the hair follicles of the control group at 17 days of the treatment (Fig. 3C). In the PBE group, IL-1β immunoreactivity was significantly lower (49.7% vs. control group) compared with that in the control group (Fig. 3D and F).

Effect of PBE on anti-inflammatory cytokines

The effect of PBE on anti-inflammatory cytokines was then assessed (Fig. 4). In the control group, immunoreactivity of IL-4 was fundamentally observed in the hair follicles at 17 days of treatment (Fig. 4A). In the PBE group, the immunoreactivity of IL-4 was significantly increased (149.6% vs. control group) when compared with that in the control group (Fig. 4B and E).

Figure 4. (A-D) Immunohistochemical analysis of IL-4 and IL-13 in the dorsal skin at 17 days after the application. IL-4 in (A) the control group and (B) 2% PBE group. IL-13 in (C) the control and (D) 2% PBE group. In the 2% PBE group, the immunoreactivities of IL-4 and IL-13 were significantly increased (arrows) as compared with those in the control group (scale bar, 50 µm). RODs of (E) IL-4 and (F) IL-13 in the dorsal skin at 17 days after the application. The bars indicate the means ± standard error of the mean (n=10 in each group). *P<0.05 vs. control group. PBE, Pinus thunbergii bark extract; ROD, relative optical density.

In addition, the immunoreactivity of IL-13 in the control group was predominantly present in the hair follicles (Fig. 4C). In the PBE group, the immunoreactivity of IL-13 was significantly enhanced (192.8% of the control group) as compared with that in the control group (Fig. 4D and F).

Effect of PBE on growth factors

The effect of PBE on growth factors was then assessed (Fig. 5). At 17 days of treatment, immunoreactivity of insulin-like growth factor (IGF)-I in the control group was weakly present in the hair follicles (Fig. 5A). In the PBE group, the immunoreactivity of IGF-I was significantly enhanced (280.2% of control group) when compared with that in the control group (Fig. 5B and E).

Figure 5. (A-D) Immunohistochemical analysis of IGF-I and VEGF in the dorsal skin at 17 days after the application. IGF-I in (A) the control group and (B) 2% PBE group. VEGF in (C) the control and (D) 2% PBE group. In the 2% PBE group, the immunoreactivities of IGF-I and VEGF were significantly increased (arrows) as compared with those in the control group (scale bar, 50 µm). RODs of (E) IGF-I and (F) VEGF in the dorsal skin at 17 days after the application. The bars indicate the means ± standard error of the mean (n=10 in each group). *P<0.05 vs. control group. PBE, Pinus thunbergii bark extract; ROD, relative optical density; IGF, insulin-like growth factor.

In addition, the immunoreactivity of VEGF in the control group was fundamentally detected in the hair follicles (Fig. 5C). In the PBE group, a significantly elevated immunoreactivity of VEGF (254.5% of control group) was observed when compared with that in the control group (Fig. 5D and F).

Discussion

The results of the present study indicated that PBE contained polyphenols (197.89±0.66 mg GAE/g), while flavonoids constituted 24.67±0.15% of the total polyphenols. Plant-derived phenolic compounds, including flavonoids and phenolic acids, have recently attracted a great deal of interest due to their diverse beneficial effects (29). For instance, Aronia melanocarpa (Rosaceae family) extract contains an abundance of chlorogenic acid (an ester of L-quinic acid and caffeic acid) and rutin (3-rhamnosyl-glucosylquercetin), which was able to prevent ultraviolet (UV) B-induced skin damage by regulating collagen fibers and metalloproteinases in mouse dorsal skin (25). In addition, Rhodomyrtus tomentosa (Myrtaceae family) fruit extract contains numerous phenolic compounds, such as flavonols, anthocyanins and stilbenes (30), and the extract ameliorates bacteria-induced acnes in human skin by reducing inflammatory lesions (31). Furthermore, it is well known that phenolic compounds occur as major ingredients in the commercialized products extracted from Korean and French pine bark (PineXol® and Pycnogenol®, respectively) (12,32,33). Pine bark extract has been widely used due to its beneficial attributes. For instance, a previous study demonstrated that oral ingestion of Pycnogenol® protected against skin damage induced by UV irradiation, modulated skin pigmentation and enhanced skin barrier function and extracellular matrix homeostasis (33). In addition, in 2020, Pavlou et al (34) reported that the bark extract of Aleppo pine (Pinus halepensis) protected keratinocytes against cigarette smoke-induced oxidative stress. Of note, a recent study reported that Pinus thunbergii extract ameliorated lipopolysaccharide-induced acute inflammatory responses by regulating oxidative stress (35). In the present study, the total phenols and total flavonoids of the PBE were analyzed; however, liquid chromatography/mass spectrometry analysis, which is frequently used to analyze specific components, was not employed.

The three representative models of alopecia in mice are as follows: i) Genetically modified C3H/HeJ mice with spontaneous alopecia; ii) mice with AGA induced by topical application of dihydrotestosterone onto the shaved dorsal skin; and iii) chemotherapy-induced alopecia induced in mice with dorsal hair shaved, followed by intraperitoneal injection of cyclophosphamide (100–125 mg/kg) (36–38). The mouse model of spontaneous alopecia is expensive to develop, in addition to the low success rate (36). Therefore, pilot experiments involving androgenetic and chemotherapy-induced alopecia models were performed by our group and no significant differences in the hair growth rate following shaving of their dorsal hair were noted. The physiological attributes of the hair growth cycle in mice differ from those in humans. In addition, alopecia is not naturally induced in mice. Based on previous studies, although mice do not undergo a vellus-to-terminal hair type switch, or suffer from AGA, they are used as an excellent model system for studying the hair cycle for several reasons (39,40): i) The first two cycles of mouse hair follicles are synchronized, while in humans, neighboring follicles cycle independently of each other when biopsy is taken; ii) the hair cycle of mice is short (~3 weeks); by contrast, human scalp hairs have a cycle time of several years and even that of vellus hairs takes months. Therefore, the short-synchronized hair cycle allows hair follicles to be harvested and examined at specific time-points in the cycle; and iii) the stages of the hair cycle have been well characterized in the mouse. Anagen is subdivided morphologically into six and catagen into eight different stages (39,40). In this regard, the current model does not completely reflect the pathophysiology of human alopecia. Of note, the hair growth-promoting effects of various treatments have been assessed and for this, the telogen phase was induced by shaving dorsal hair in mice (3,41–43). Based on these experimental data, shaving dorsal hair is regarded as acceptable to assess the hair growth-promoting effect.

In the present study, to investigate the hair growth-promoting effect of PBE, the shaved dorsal skin of mice was treated with DW or 1, 2 and 4% PBE. The results revealed significant hair growth promotion at 17 days of topical application of 2 and 4% PBE. However, no differences in cellular distribution and morphology of the dorsal skin tissue were detected following saline or PBE treatment. Accordingly, the optimal dose of PBE to effectively facilitate hair growth was determined as 2% PBE.

Inflammatory phenomena are increasingly being recognized as an integral part of the progress of AGA (44,45). In AGA, the inflammatory response associated with connective tissue remodeling leads to permanent hair loss (45). In addition, TE, which is another cause of diffuse hair loss, is triggered by stress, shock or traumatic events (46,47). In AGA, scalp biopsies from both male and female patients exhibited follicular micro-inflammation and lymphocytic folliculitis following exposure to immunological stress (44,48). In addition, biopsies of non-scarring alopecia had inflammation in hair follicles in >20% of cases (49). A previous study by our group demonstrated the hair growth-promoting effect of Angelica gigas Nakai (Umbelliferae family) root extract mediated via regulating inflammatory cytokines (3). In that study, the regulated pro- and anti-inflammatory cytokines, which were controlled by topical application with root extract of Angelica gigas Nakai, were attributed to upregulation of high-mobility group box 1 (HMGB1) protein, which is an inflammatory modulator of the peri-follicular regions. Furthermore, in 2019, Hwang et al (11) reported that HMGB1 modulated prostaglandin E2 (PGE2) metabolism, which was closely associated with inflammatory response, and represented a potential therapeutic target in alopecia. In addition, a precedent study reported that IL-4 enhanced the hair cycle/growth in a mouse model of hapten-induced contact hypersensitivity (50). Furthermore, the previous study by our group indicated that the enhancement of both IL-4 and IL-13 contributed to the hair growth-promoting effect (3). Based on these studies, the effects may be related to the upregulation of IL-4 and IL-13, which may have a hair growth-promoting effect.

Based on the preliminary results, 2% PBE was applied to the dorsal skin and a significant reduction in the levels of pro-inflammatory cytokines (TNF-α and IL-1β) and an apparent increase in anti-inflammatory cytokines (IL-4 and IL-13) was observed in the hair follicles. Pro-inflammatory cytokines, which are produced by activated immune cells, induce advanced inflammatory response (51). By contrast, anti-inflammatory cytokines act as antagonists of pro-inflammatory cytokines by suppressing their expression and inhibiting their receptors (52). The present study did not investigate the potential active ingredient(s) of PBE. However, accumulating data indicate that maritime pine bark extract contains high levels of procyanidins and proanthocyanidins (18,53,54). Based on previous studies, the bark extract of Pinus thunbergii, which is a Korean maritime pine, may also contain procyanidins and proanthocyanidins. In addition, it has been reported that these two components exert anti-inflammatory activity (55,56). Taken together, the phenolic compounds including flavonoids contained in the PBE contribute to excellent anti-inflammatory effects (57,58).

In addition, the results of the present study suggested that the immunoreactivity of IGF-I and VEGF was significantly increased in the hair follicles at 17 days of PBE treatment. Accumulating experimental evidence demonstrated that growth factors, such as IGF-I, VEGF, fibroblast growth factor and epidermal growth factor, stimulate hair growth in vitro and in vivo (10,59–61). Among these growth factors, IGF-I, a potent mitogen assisting cell growth in diverse types of tissues and cells, potently stimulates hair growth. For instance, exogenous IGF-I promotes hair shaft elongation in human hair follicle cells by increasing platelet-derived growth factor, which induces anagen phase in the hair growth cycle (59). VEGF, a growth factor stimulating vasculogenesis and angiogenesis, also facilitates hair growth by providing nutrients to the hair follicles (62). In 2001, Yano et al (10) reported that hair follicle-derived VEGF enhanced perifollicular angiogenesis and increased the number and size of hair follicles in mouse dorsal skin. Furthermore, in 2020, Ahn et al (8) reported that topical application with a mixture of Platycladus orientalis (L.) Franco (Cupressaceae family) leaf extract and α-terpineol promoted hair growth in mouse dorsal skin by elevating both IGF-I and VEGF levels in the hair follicles. Taken together, the phenolic compounds including flavonoids present in the PBE were indicated to contribute to hair growth promotion by increasing IGF and VEGF.

In the present study, no in vitro experiments were performed due to technical limitations and no western blot analysis was performed. Therefore, in the future, the mechanisms of the hair growth-promoting effect of PBE will be investigated using in vitro approaches and western blot analysis and identify a dissolvent that is harmless to the skin and may enhance the hair growth-promoting effect of PBE. In addition, the results of the present study revealed elevated VEGF following topical application of PBE. However, the degrees of vasodilation and angiogenesis were not assessed; therefore, it is suggested that PBE application-induced changes in vasodilation and angiogenesis require to be examined in the future.

In conclusion, the experimental results of the present study suggested that PBE contained polyphenols (197.89±0.66 mg GAE/g) and flavonoids (48.82±0.14 mg QE/g), which exerted strong anti-inflammatory activity. A hair growth-promoting effect in mouse dorsal skin was achieved with 1, 2 and 4% PBE, and 2% PBE effectively promoted hair growth at 17 days of application. To investigate the mechanisms of the hair growth promotion, changes in inflammatory cytokines and growth factors in the hair follicles were immunohistochemically analyzed following treatment with 2% PBE, revealing that PBE treatment modulated inflammatory responses by reducing the levels of pro-inflammatory cytokines (TNF-α and IL-1β) and enhancing the levels of anti-inflammatory cytokines (IL-4 and IL-13). Furthermore, certain growth factors (IGF-I and VEGF) were significantly increased in the hair follicles. Based on these results, it is strongly suggested that 2% PBE may be utilized in applications targeting hair growth promotion or hair loss prevention.

Acknowledgements

The authors would like to express their appreciation to Mr. Seung Uk Lee (Department of Neurobiology, School of Medicine, Kangwon National University) and Ms. Hyun Sook Kim (Department of Biomedical Science and Research Institute for Bioscience and Biotechnology, Hallym University) for their technical help with this work.

Funding

This work was supported by the Basic Science Research Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Education (grant no. NRF-2019R1A6A1A11036849) and by the Agriculture, Food and Rural Affairs Convergence Technologies Program for Educating Creative Global Leader (grant no. 714001-07), Ministry of Agriculture, Food and Rural Affairs.

Availability of data and materials

All data produced and analyzed in the current study are available from the corresponding author on reasonable request.

Authors' contributions

YH and TKL wrote the draft of the manuscript. JCL, DWK, SYC, MHW and SSK were responsible for experimental conceptualization, data curation and data analysis. YH, TKL, HS, JKH, JWL and JDK performed experiments and data collection and data analysis. TKL and MHW confirm the authenticity of the raw data. SYC, MHW and SSK reviewed and edited the manuscript and acquired funding. All authors read and approved the final manuscript.

Ethics approval and consent to participate

The experimental procedures using the experimental animals strictly adhered to the ‘Current international laws and policies’ in the ‘Guide for the Care and Use of Laboratory Animals’ (24) and approved by the Institutional Animal Care and Use Committee at Kangwon National University (Chuncheon, Republic of Korea; approval no. KW-200114-1; approval date, Jan. 22, 2020).

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Glossary

Abbreviations

Abbreviations:

References